Search research articles
Contact Us
Filters
Showing results (31-40 of 76) with videos related to
Page
of 8
Sort By:
International Journal of Oncology
|
December 22, 2007
Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling
Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Ramon Colomer, et al.
International Journal of Molecular Medicine
|
June 6, 2007
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)
Laura Ferrer-Soler, Alejandro Vazquez-Martin, Joan Brunet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 6, 2004
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
Javier A Menendez, Luciano Vellon, Inderjit Mehmi, et al.
Molecular Carcinogenesis
|
July 11, 2007
BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer
Joan Brunet, Alejandro Vazquez-Martin, Ramon Colomer, et al.
Oncology
|
January 17, 2024
Is Older Age an Independent Prognostic Factor of Survival in Metastatic Colorectal Cancer?
Patricia Toquero, Rebeca Mondéjar, Nuria Romero-Laorden, et al.
Breast Cancer Research : BCR
|
May 26, 2019
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
Miguel Quintela-Fandino, Juan V Apala, Diego Malon, et al.
Peptides
|
August 17, 2010
Antimicrobial cyclic decapeptides with anticancer activity
Lidia Feliu, Glòria Oliveras, Anna D Cirac, et al.
Cancers
|
June 24, 2022
The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair
Vilma Pacheco-Barcia, Andrés Muñoz, Elena Castro, et al.
Breast Cancer Research and Treatment
|
June 13, 2002
Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells
Javier Abel Menéndez, Santiago Ropero, Maria Mar del Barbacid, et al.
Oncotarget
|
March 7, 2015
Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant basal-HER2 subtype of breast cancer
Begoña Martin-Castillo, Eugeni Lopez-Bonet, Maria Buxó, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 76) with videos related to
Sort By:
Page
of 8
International Journal of Oncology
|
December 22, 2007
Sequence-dependent synergism and antagonism between paclitaxel and gemcitabine in breast cancer cells: the importance of scheduling
Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Ramon Colomer, et al.
International Journal of Molecular Medicine
|
June 6, 2007
An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review)
Laura Ferrer-Soler, Alejandro Vazquez-Martin, Joan Brunet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 6, 2004
Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells
Javier A Menendez, Luciano Vellon, Inderjit Mehmi, et al.
Molecular Carcinogenesis
|
July 11, 2007
BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer
Joan Brunet, Alejandro Vazquez-Martin, Ramon Colomer, et al.
Oncology
|
January 17, 2024
Is Older Age an Independent Prognostic Factor of Survival in Metastatic Colorectal Cancer?
Patricia Toquero, Rebeca Mondéjar, Nuria Romero-Laorden, et al.
Breast Cancer Research : BCR
|
May 26, 2019
Nintedanib plus letrozole in early breast cancer: a phase 0/I pharmacodynamic, pharmacokinetic, and safety clinical trial of combined FGFR1 and aromatase inhibition
Miguel Quintela-Fandino, Juan V Apala, Diego Malon, et al.
Peptides
|
August 17, 2010
Antimicrobial cyclic decapeptides with anticancer activity
Lidia Feliu, Glòria Oliveras, Anna D Cirac, et al.
Cancers
|
June 24, 2022
The Homologous Recombination Deficiency Scar in Advanced Cancer: Agnostic Targeting of Damaged DNA Repair
Vilma Pacheco-Barcia, Andrés Muñoz, Elena Castro, et al.
Breast Cancer Research and Treatment
|
June 13, 2002
Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells
Javier Abel Menéndez, Santiago Ropero, Maria Mar del Barbacid, et al.
Oncotarget
|
March 7, 2015
Cytokeratin 5/6 fingerprinting in HER2-positive tumors identifies a poor prognosis and trastuzumab-resistant basal-HER2 subtype of breast cancer
Begoña Martin-Castillo, Eugeni Lopez-Bonet, Maria Buxó, et al.
Page
of 8